You are on the new improved site. You can view the old site in view-only mode here until June 27, 2026

Filter Results

Search all journals

Enter search terms…

Advanced search

/

About

About Sage
About Sage Journals
Privacy Policy
Terms of Use
Contact Us
Help

Information for

Authors
Editors
Librarians
Researchers
Reviewers
Frequently asked questions

Copyright © 2026 by Sage Publications.京ICP备09090397号-11

Search results

Search results page

Articles (639)

Journals (0)

1-10 of 639 results for receptor tyrosine kinase inhibitor

Sort by:

Relevance

Select all

Select all

Sort by:

Relevance

Select article: Cardiovascular Effects in Rats following Exposure to a Receptor Tyrosine Kinase Inhibitor

Free access

Research article

First published 2010-4

Cardiovascular Effects in Rats following Exposure to a Receptor Tyrosine Kinase Inhibitor

Shirley A. Aguirre, Jonathan R. Heyen, Walter Collette [...]

Toxicologic Pathology

Select article: NF-κB as the main node of resistance to receptor tyrosine kinase inhibitors in triple-negative breast cancer

Open access

Review article

First published 2017-6

NF-κB as the main node of resistance to receptor tyrosine kinase inhibitors in triple-negative breast cancer

Behrad Darvishi, Leila Farahmand, Zahra Eslami-S [...]

Tumor Biology

Select article: Factors associated with efficacy of first-generation epidermal growth factor receptor tyrosine kinase inhibitors in non-small-cell lung cancer

Open access

Review article

First published 2017-5

Factors associated with efficacy of first-generation epidermal growth factor receptor tyrosine kinase inhibitors in non-small-cell lung cancer

Shaohua Cui, Liyan Jiang

Tumor Biology

Select article: Design,synthesis,and antitumor activity of novel benzoheterocycle derivatives as inhibitors of vascular endothelial growth factor receptor-2 tyrosine kinase

Free access

Research article

First published 2020-5

Design,synthesis,and antitumor activity of novel benzoheterocycle derivatives as inhibitors of vascular endothelial growth factor receptor-2 tyrosine kinase

Yangyang Ding, Kai Liu, Xinyu Zhao [...]

Journal of Chemical Research

Select article: Vascular endothelial growth factor receptor tyrosine kinase inhibitors in metastatic renal cell cancer: latest results and clinical implications

Free access

Research article

First published 2013-11

Vascular endothelial growth factor receptor tyrosine kinase inhibitors in metastatic renal cell cancer: latest results and clinical implications

Shahzeena Aslam, Tim Eisen

Therapeutic Advances in Medical Oncology

Select article: Tyrosine kinase inhibitors for epidermal growth factor receptor gene mutation–positive non-small cell lung cancers: an update for recent advances in therapeutics

Retricted access

Review article

First published 2016-6

Tyrosine kinase inhibitors for epidermal growth factor receptor gene mutation–positive non-small cell lung cancers: an update for recent advances in therapeutics

Clement Chung

Journal of Oncology Pharmacy Practice

Select article: Clinical approaches to treat patients with non-small cell lung cancer and epidermal growth factor receptor tyrosine kinase inhibitor acquired resistance

Free access

Review article

First published 2015-10

Clinical approaches to treat patients with non-small cell lung cancer and epidermal growth factor receptor tyrosine kinase inhibitor acquired resistance

Alfredo Tartarone, Rosa Lerose

Therapeutic Advances in Respiratory Disease

Select article: Inhibition of Growth and Metastasis of Human Pancreatic Cancer Growing in Nude Mice by PTK 787/ZK222584,an Inhibitor of the Vascular Endothelial Growth Factor Receptor Tyrosine Kinases

Retricted access

Research article

First published 2001-10

Inhibition of Growth and Metastasis of Human Pancreatic Cancer Growing in Nude Mice by PTK 787/ZK222584,an Inhibitor of the Vascular Endothelial Growth Factor Receptor Tyrosine Kinases

Carmen C. Solorzano, Cheryl H. Baker, Christiane J. Bruns [...]

Cancer Biotherapy and Radiopharmaceuticals

Select article: Osimertinib: A third-generation tyrosine kinase inhibitor for treatment of epidermal growth factor receptor-mutated non-small cell lung cancer with the acquired Thr790Met mutation

Retricted access

Review article

First published 2018-7

Osimertinib: A third-generation tyrosine kinase inhibitor for treatment of epidermal growth factor receptor-mutated non-small cell lung cancer with the acquired Thr790Met mutation

Meredith K Bollinger, Amanda S Agnew, Gerard P Mascara

Journal of Oncology Pharmacy Practice

Select article: Comparison of pemetrexed and docetaxel as salvage chemotherapy for the treatment for nonsmall-cell lung cancer after the failure of epidermal growth factor receptor-tyrosine kinase inhibitors

Open access

Research article

First published 2014-2

Comparison of pemetrexed and docetaxel as salvage chemotherapy for the treatment for nonsmall-cell lung cancer after the failure of epidermal growth factor receptor-tyrosine kinase inhibitors

Lei Dong, Zhao-feng Han, Zi-hui Feng [...]

Journal of International Medical Research

1
2
3
•••
64
10 / page

Article type

Publication date

Subjects

Access